278 related articles for article (PubMed ID: 17075842)
1. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific stimulation of the maternal immune system. I. Effects On teratogen-induced fetal malformations.
Holladay SD; Sharova L; Smith BJ; Gogal RM; Ward DL; Blaylock BL
Teratology; 2000 Dec; 62(6):413-9. PubMed ID: 11091363
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryopathy in ICR mice.
Punareewattana K; Holladay SD
Birth Defects Res A Clin Mol Teratol; 2004 Jan; 70(1):20-7. PubMed ID: 14745891
[TBL] [Abstract][Full Text] [Related]
4. Reduction in valproic acid-induced neural tube defects by maternal immune stimulation: role of apoptosis.
Mallela M; Hrubec T
Birth Defects Res B Dev Reprod Toxicol; 2012 Aug; 95(4):296-303. PubMed ID: 22767483
[TBL] [Abstract][Full Text] [Related]
5. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice.
Laudermilch CL; Holladay SD; Sponenberg DP; Saunders GK; Ward DL; Prater MR
Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):597-604. PubMed ID: 16080182
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus.
Sharova L; Sura P; Smith BJ; Gogal RM; Sharov AA; Ward DL; Holladay SD
Teratology; 2000 Dec; 62(6):420-8. PubMed ID: 11091364
[TBL] [Abstract][Full Text] [Related]
7. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice.
Punareewattana K; Sharova LV; Li W; Ward DL; Holladay SD
Int Immunopharmacol; 2003 Nov; 3(12):1639-55. PubMed ID: 14555289
[TBL] [Abstract][Full Text] [Related]
8. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation.
Hrubec TC; Prater MR; Toops KA; Holladay SD
Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):1-9. PubMed ID: 16342200
[TBL] [Abstract][Full Text] [Related]
9. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
10. Immune stimulation in urethane-exposed pregnant mice increases expression level of spleen leukocyte genes for TGFbeta3 GM-CSF and other cytokines that may play a role in reduced chemical-induced birth defects.
Sharova LV; Gogal RM; Sharov AA; Chrisman MV; Holladay SD
Int Immunopharmacol; 2002 Sep; 2(10):1477-89. PubMed ID: 12400877
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
13. Modulation of diabetes-induced palate defects by maternal immune stimulation.
Hrubec TC; Toops KA; Holladay SD
Anat Rec (Hoboken); 2009 Feb; 292(2):271-6. PubMed ID: 19089897
[TBL] [Abstract][Full Text] [Related]
14. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement.
Prater MR; Zimmerman KL; Ward DL; Holladay SD
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):862-9. PubMed ID: 15526292
[TBL] [Abstract][Full Text] [Related]
15. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.
Robertson SA; Roberts CT; Farr KL; Dunn AR; Seamark RF
Biol Reprod; 1999 Feb; 60(2):251-61. PubMed ID: 9915988
[TBL] [Abstract][Full Text] [Related]
16. Contributions of dam and conceptus to differences in sensitivity to valproic acid among C57 black and SWV mice.
Beck SL
Reprod Toxicol; 1999; 13(5):353-60. PubMed ID: 10560583
[TBL] [Abstract][Full Text] [Related]
17. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
18. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Sato M; Shirota M; Nagao T
Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
[TBL] [Abstract][Full Text] [Related]
19. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
20. Ethanol potentiates valproic acid-induced neural tube defects (NTDs) in mice due to toxicokinetic interactions.
Elmazar MM; Nau H
Reprod Toxicol; 1995; 9(5):427-33. PubMed ID: 8563186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
